Code Life Research Awards Ceremony
Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation
Two RI-MUHC trainees awarded 2023 Vanier Canada Graduate Scholarship
Congratulations to Michelle Le and Sarah Maritan!
Record turnout for Summer Student Research Day at the RI-MUHC
This annual event gives summer students a unique opportunity to present their projects to the research community
New understanding of processes involved in breast cancer metastasis
A study led by RI-MUHC researcher Nathalie Lamarche-Vane reveals the mechanisms underlying regulation...
Collaborating with industry to develop lipid nanoparticles
RI-MUHC researcher Julia Burnier heads one of two projects selected for funding by Moderna
Celebrating Pride Month with the first Pride in Research seminar
The RI-MUHC led a one-hour webinar to explore the perspectives of LGBTQIA2S+ people in the research space
New research aims to make prostate cancer prognostics more precise
A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer
New advances in lung cancer treatment
Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer
Medical cannabis a valuable option for cancer pain relief
A new study conducted at the RI-MUHC suggests that, as a complementary therapy for cancer patients, medical cannabis could be used safely...
New funding to address chemotherapy resistance in esophageal cancer
RI-MUHC researchers have received $7.5 million from the Canadian Cancer Society and the Canadian Institutes of Health...